TVGN — Tevogen Bio Holdings Balance Sheet
0.000.00%
Annual balance sheet for Tevogen Bio Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 7.12 | 5.48 | 1.05 | 1.28 | 0.552 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 0 | 0.159 | 0.159 |
| Prepaid Expenses | |||||
| Total Current Assets | 7.17 | 5.84 | 1.72 | 2.36 | 1.54 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.143 | 1.31 | 0.929 | 0.525 | 1.59 |
| Other Long Term Assets | |||||
| Total Assets | 7.66 | 7.74 | 5.51 | 3.46 | 4.38 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.668 | 1.96 | 85.5 | 9.04 | 7.07 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 24.1 | 41.7 | 99.9 | 10.1 | 12.6 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -16.5 | -34 | -94.4 | -6.67 | -8.23 |
| Total Liabilities & Shareholders' Equity | 7.66 | 7.74 | 5.51 | 3.46 | 4.38 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |